Literature DB >> 29475922

DCLK1 Expression in Colorectal Polyps Increases with the Severity of Dysplasia.

Aki Takiyama1, Toshiaki Tanaka2, Shinsuke Kazama3, Hiroshi Nagata2, Kazushige Kawai2, Keisuke Hata2, Kensuke Otani2, Takeshi Nishikawa2, Kazuhito Sasaki2, Manabu Kaneko2, Shigenobu Emoto2, Koji Murono2, Hirotoshi Takiyama2, Hiroaki Nozawa2.   

Abstract

BACKGROUND: The expression of doublecortin-like kinase 1 (DCLK1) has been investigated in cancer; however not in precancerous adenomatous polyps.
MATERIALS AND METHODS: Immunohistological expression of DCLK1 was evaluated in various grades of adenomas, cancerous polyps, and hyperplastic polyps in resected human tissue specimens.
RESULTS: Ninety-two specimens were positive for DCLK1 and 134 were negative. Cancerous polyps showed a high DCLK1 positivity rate compared to adenomas (68.4% vs. 36.8%; p<0.01). The rate of DCLK1 positivity was not significantly different among the three grades of adenomas (mild, moderate, and severe). DCLK1 was highly positive in advanced adenomas than low risk adenomas (49.6% vs. 29.3%; p<0.01).
CONCLUSION: The expression of DCLK1 was found in low-grade adenomas and increased with worsening severity of dysplasia. DCLK1 expression was highly observed in advanced adenomas, which had a clinically higher malignant potential. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Cancer stem cell; colorectal adenoma; colorectal cancer; colorectal polyp; doublecortin-like kinase 1

Mesh:

Substances:

Year:  2018        PMID: 29475922      PMCID: PMC5905207          DOI: 10.21873/invivo.11247

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  42 in total

1.  Immunohistochemical features of CD133 expression: association with resistance to chemoradiotherapy in rectal cancer.

Authors:  Susumu Saigusa; Koji Tanaka; Yuji Toiyama; Takeshi Yokoe; Yoshinaga Okugawa; Aya Kawamoto; Hiromi Yasuda; Yuki Morimoto; Hiroyuki Fujikawa; Yasuhiro Inoue; Chikao Miki; Masato Kusunoki
Journal:  Oncol Rep       Date:  2010-08       Impact factor: 3.906

Review 2.  The advanced adenoma as the primary target of screening.

Authors:  Sidney J Winawer; Ann G Zauber
Journal:  Gastrointest Endosc Clin N Am       Date:  2002-01

3.  Pancreatic Neuroendocrine Tumors and EMT Behavior Are Driven by the CSC Marker DCLK1.

Authors:  Yu Ikezono; Hironori Koga; Jun Akiba; Mitsuhiko Abe; Takafumi Yoshida; Fumitaka Wada; Toru Nakamura; Hideki Iwamoto; Atsutaka Masuda; Takahiko Sakaue; Hirohisa Yano; Osamu Tsuruta; Takuji Torimura
Journal:  Mol Cancer Res       Date:  2017-02-08       Impact factor: 5.852

4.  Genome-wide copy number changes and CD133 expression characterized distinct subset of colon polyps: differentiation between incidental polyps and cancer-associated polyps.

Authors:  Chih-Yung Yang; Ju-Yu Tseng; Chian-Feng Chen; Teh-Ying Chou; Hong-Wei Gao; Chia-Ling Hua; Chi-Hung Lin; Jen-Kou Lin; Jeng-Kai Jiang
Journal:  Int J Colorectal Dis       Date:  2015-07-24       Impact factor: 2.571

5.  Immunolocalization of DCAMKL-1, a putative intestinal stem cell marker, in normal colonic tissue.

Authors:  Giuseppe Gagliardi; Krzysztof Moroz; Charles F Bellows
Journal:  Pathol Res Pract       Date:  2012-06-30       Impact factor: 3.250

6.  Distribution of intestinal stem cell markers in colorectal precancerous lesions.

Authors:  Bo Gun Jang; Hye Sung Kim; Kyung Ju Kim; Ye-Young Rhee; Woo Ho Kim; Gyeong Hoon Kang
Journal:  Histopathology       Date:  2015-09-11       Impact factor: 5.087

7.  In vivo imaging of Lgr5-positive cell populations using confocal laser endomicroscopy during early colon tumorigenesis.

Authors:  Jin Woo Choi; Jun Ki Kim; Myunghwan Choi; Yi Rang Kim; Seok Hyun Yun
Journal:  Endoscopy       Date:  2014-09-12       Impact factor: 10.093

8.  A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas.

Authors:  S Detre; G Saclani Jotti; M Dowsett
Journal:  J Clin Pathol       Date:  1995-09       Impact factor: 3.411

9.  DCLK1 facilitates intestinal tumor growth via enhancing pluripotency and epithelial mesenchymal transition.

Authors:  Parthasarathy Chandrakesan; Nathaniel Weygant; Randal May; Dongfeng Qu; Harisha R Chinthalapally; Sripathi M Sureban; Naushad Ali; Stan A Lightfoot; Shahid Umar; Courtney W Houchen
Journal:  Oncotarget       Date:  2014-10-15

10.  Intestinal tuft cells regulate the ATM mediated DNA Damage response via Dclk1 dependent mechanism for crypt restitution following radiation injury.

Authors:  Parthasarathy Chandrakesan; Randal May; Nathaniel Weygant; Dongfeng Qu; William L Berry; Sripathi M Sureban; Naushad Ali; Chinthalapally Rao; Mark Huycke; Michael S Bronze; Courtney W Houchen
Journal:  Sci Rep       Date:  2016-11-23       Impact factor: 4.996

View more
  2 in total

1.  DCLK1 promotes colorectal cancer stemness and aggressiveness via the XRCC5/COX2 axis.

Authors:  Jee-Heun Kim; So-Yeon Park; So-El Jeon; Jang-Hyun Choi; Choong-Jae Lee; Tae-Young Jang; Hyeon-Ji Yun; Yuno Lee; Pilho Kim; Sang Hee Cho; Ji Shin Lee; Jeong-Seok Nam
Journal:  Theranostics       Date:  2022-07-04       Impact factor: 11.600

2.  Saffron Crudes and Compounds Restrict MACC1-Dependent Cell Proliferation and Migration of Colorectal Cancer Cells.

Authors:  Nazli Güllü; Dennis Kobelt; Hassan Brim; Shaman Rahman; Lena Timm; Janice Smith; Akbar Soleimani; Stefano Di Marco; Silvia Bisti; Hassan Ashktorab; Ulrike Stein
Journal:  Cells       Date:  2020-08-03       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.